Digital Therapeutics

Learn more about these software-based interventions that prevent, manage, or treat medical conditions. Our resources cover the latest advancements, evidence-based applications, and implementation strategies to help healthcare professionals integrate digital therapeutics into patient care for improved health outcomes. Learn more AMCP's legislative efforts to expand coverage of prescription digital therapeutics (PDTs).

 

Digital Therapeutics, Physician and Patient

AMCP Digital Therapeutics Advisory Group

The Digital Therapeutics Advisory Group is focused on developing resources for payers on when they should evaluate products, what manufacturers should communicate, and understanding how Digital Therapeutics are included in drug compendia. This advisory group is active from March 2022-February 2023.
Digital Therapeutics
Digital Therapeutics Partnership Forum

Digital Therapeutics 2.0

Partnership Forum: This forum identified challenges and payer needs related to the evidence for digital therapeutics. The forum explored the current market space for digital therapeutics including the evidence for the products, place in therapy, monitoring or utilization metrics and barriers that patients face in obtaining therapies. Proceedings are now available.
Digital Therapeutics

Why PIE and the Prescription Digital Therapeutics Act Matter: Recap of AMCP Legislative Days

On May 18, 2022, AMCP hosted Legislative Days where AMCP members and the AMCP Policy and Government Relations team met virtually with U.S. Senators and Representatives to advocate for AMCP's top policy priorities. Learn more about the role Legislative Days plays in achieving our mission to improve patient health by ensuring access to high-quality, cost-effective medications and other therapies.
Digital Therapeutics